EN HU
logo Tudóstér

Borbás Anikó

Borbás Anikó
University of Debrecen Faculty of Pharmacy
Department of Pharmaceutical Chemistry
professor, head, Department of Pharmaceutical Chemistry

Publication list

Tudóstér co-authors statistics filterable publication list
Uploaded publications:
188
Publications in DEA:
177
OA:
75
Date range:
1991-2025
2025
1.
Bege, M., Kattoub, R. G., Borbás, A.: Avacincaptad pegol, the second approved aptamer medicine: a mini review.
DRem. 1 (2), 29-45, 2025.
doi DEA
2.
Bege, M., Borbás, A.: New anticancer medicines approved by the EMA in 2024.
DRem. 1 (2), 46-56, 2025.
doi DEA
3.
Kelemen, V., Bege, M., Debreczeni, N., Bereczki, I., Bényei, A., Herczegh, P., Borbás, A.: Stereoselective Synthesis of 1,2-cis-alpha-Glycosyl Thiols and Trehalose-Type alpha,alpha'-Thiodisaccharides by Cryo Thiol-Ene Photocoupling - Thio-Click Reaction in Frozen State.
Chem.-Eur. J. [Epub ahead of print], 1-10, (article identifier: 202500104), 2025.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis (2024)
Q1 Chemistry (miscellaneous) (2024)
Q1 Organic Chemistry (2024)
4.
Bege, M., Lovas, M., Priksz, D., Bernát, B., Bereczki, I., Kattoub, R. G., Kajtár, R., Eskeif, S., Novák, L., Hodek, J., Weber, J., Herczegh, P., Lekli, I., Borbás, A.: Synthesis, H2S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5'-dithioacetates.
Sci Rep. 15 (1), 2876-2881, 2025.
doi DEA WoS Scopus
Journal metrics:
Q1 Multidisciplinary (2024)
5.
Bege, M., Leiner, K., Lovas, M., Pető, R., Bereczki, I., Hodek, J., Weber, J., Kuczmog, A., Borbás, A.: Synthesis of 3'-modified xylofuranosyl nucleosides bearing 5'-silyl or -butyryl groups and their antiviral effect against RNA viruses.
Eur. J. Pharm. Sci. 209, 1-12, (article identifier: 107107), 2025.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmaceutical Science (2024)
6.
Bege, M., Kattoub, R. G., Borbás, A.: The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: history, Recent Advances and Future Prospects of Aptamers in Therapy.
Pharmaceutics. 17 (3), 394-, 2025.
doi DEA
Journal metrics:
D1 Pharmaceutical Science (2024)
2024
7.
Faltinek, L., Melicher, F., Kelemen, V., Mező, E., Borbás, A., Wimmerová, M.: Bispecific Thio-Linked Disaccharides as Inhibitors of Pseudomonas Aeruginosa Lectins LecA (PA-IL) and LecB (PAIIL): dual-Targeting Strategy.
Chem.-Eur. J. 30, 1-10, (article identifier: 202403546), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Chemistry (miscellaneous)
Q1 Organic Chemistry
8.
Herczeg, M., Demeter, F., Nagy, T., Rusznyák, Á., Hodek, J., Sipos, É., Lekli, I., Fenyvesi, F., Weber, J., Kéki, S., Borbás, A.: Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.
Int. J. Mol. Sci. 25 (1), 1-29, (article identifier: 677), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
9.
Tánczos, B., Vass, V., Szabó, E., Lovas, M., Kattoub, R. G., Bereczki, I., Borbás, A., Herczegh, P., Tósaki, Á.: Effects of H2S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts.
Eur. J. Pharm. Sci. 195, 1-15, (article identifier: 106721), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Pharmaceutical Science
10.
Bege, M., Borbás, A.: Medicines for influencing the posttranslational modifications of histones - a tutorial review.
DRem. 1 (1), 1-13, 2024.
doi DEA
11.
Hőgye, F., Farkas, L. B., Balogh, Á. K., Szilágyi, L., Samar, A., Bajza, I., Borbás, A., Fehér, K., Illyés, T. Z., Timári, I.: Saturation Transfer Difference NMR and Molecular DockingInteraction Study of Aralkyl-Thiodigalactosides as Potential Inhibitors of the Human-Galectin-3 Protein.
Int. J. Mol. Sci. 25 (3), 1-18, (article identifier: 1742), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
12.
Demeter, F., Peleskei, Z., Kútvölgyi, K., Rusznyák, Á., Fenyvesi, F., Kajtár, R., Sipos, É., Lekli, I., Molnár, P., Szöllősi, A. G., Lisztes, E., Tóth, I. B., Borbás, A., Herczeg, M.: Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.
Biomolecules. 14 (9), 1-24, (article identifier: 1052), 2024.
doi DEA
Journal metrics:
Q1 Biochemistry
Q2 Molecular Biology
13.
Bege, M., Borbás, A.: The Design, Synthesis and Mechanism of Action of Paxlovid, a Protease Inhibitor Drug Combination for the Treatment of COVID-19.
Pharmaceutics. 16 (2), 1-17, (article identifier: 217), 2024.
doi DEA WoS Scopus
Journal metrics:
D1 Pharmaceutical Science
14.
Óvári, I., Viczján, G., Bege, M., Borbás, A., Herczegh, P., Zsuga, J., Papp, Z., Szilvássy, Z., Juhász, B., Gesztelyi, R., Erdei, T. D.: The ex vivo effects of hypoxanthine-tricyclano, a synthetic adenosine analogue, on rat left and right atria.
Gen. Physiol. Biophys. 43 (6), 577-584, 2024.
doi DEA Scopus
Journal metrics:
Q3 Biophysics
Q3 Medicine (miscellaneous)
Q4 Physiology
15.
Kelemen, V., Csiszár, M., Borbás, A.: Toward synthesis of thioglycosyl-phosphonate analogues of lipid II.
DRem. 1 (1), 15-24, 2024.
doi DEA
2023
16.
Godoy, A. S., Nakamura, A. M., Douangamath, A., Song, Y., Noske, G. D., Gawriljuk, V. O., Fernandes, R. S., Pereira, H. D. M., Oliveira, K. I. Z., Fearon, D., Dias, A., Krojer, T., Fairhead, M., Powell, A., Dunnet, L., Brandao-Neto, J., Skyner, R., Chalk, R., Bajusz, D., Bege, M., Borbás, A., Keserű, G. M., Delft, F. v., Oliva, G.: Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease.
Nucleic Acids Res. 51 (10), 5255-5270, 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Genetics
17.
Lőrincz, E. B., Herczeg, M., Houser, J., Rievajová, M., Kuki, Á., Malinovská, L., Naesens, L., Wimmerová, M., Borbás, A., Herczegh, P., Bereczki, I.: Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase.
Int. J. Mol. Sci. 24, 1-23, (article identifier: 17268), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
18.
Demeter, F., Török, P., Kiss, A., Kovásznai-Oláh, R., Máthéné Szigeti, Z., Baksa, V., Kovács, F., Balla, N., Fenyvesi, F., Váradi, J., Borbás, A., Herczeg, M.: First Synthesis of DBU-Conjugated Cationic Carbohydrate Derivatives and Investigation of Their Antibacterial and Antifungal Activity.
Int. J. Mol. Sci. 24 (4), 1-20, (article identifier: 3550), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
19.
Bege, M., Singh, V., Sharma, N., Debreczeni, N., Bereczki, I., Herczegh, P., Rathi, B., Singh, S., Borbás, A.: In vitro and in vivo antiplasmodial evaluation of sugar-modified nucleoside analogues.
Sci. Rep. 13 (1), 1-8, (article identifier: 12228), 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Multidisciplinary
20.
Kovács, T., Lajter, I., Kúsz, N., Schelz, Z., Bózsity-Faragó, N., Borbás, A., Zupkó, I., Krupitza, G., Frisch, R., Hohmann, J., Vasas, A., Mándi, A.: Isolation and NMR Scaling Factors for the Structure Determination of Lobatolide H, a Flexible Sesquiterpene from Neurolaena lobata.
Int. J. Mol. Sci. 24 (6), 1-19, (article identifier: 5841), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
21.
Lőrincz, E. B., Tóth, G., Spolárics, J., Herczeg, M., Hodek, J., Zupkó, I., Minorics, R., Ádám, D., Oláh, A., Zouboulis, C. C., Weber, J., Nagy, L., Ostorházi, E., Bácskay, I., Borbás, A., Herczegh, P., Bereczki, I.: Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives.
Sci. Rep. 13 (1), 19618, (article identifier: 19618), 2023.
doi DEA WoS Scopus
Journal metrics:
D1 Multidisciplinary
22.
Debreczeni, N., Hotzi, J., Bege, M., Lovas, M., Mező, E., Bereczki, I., Herczegh, P., Kiss, L., Borbás, A.: N-Fluoroalkylated Morpholinos - a New Class of Nucleoside Analogues.
Chem.-Eur. J. 29 (11), 1-16, (article identifier: 202203248), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Chemistry (miscellaneous)
Q1 Organic Chemistry
23.
Szőke, K., Kajtár, R., Gyöngyösi, A., Czompa, A., Fésüs, A., Lőrincz, E. B., Petróczi, D. F., Herczegh, P., Bak, I., Borbás, A., Bereczki, I., Lekli, I.: Pharmacological Evaluation of Newly Synthesized Cannabidiol Derivates on H9c2 Cells.
Antioxidants. 12 (9), 1-15, (article identifier: 1714), 2023.
DEA WoS Scopus
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
D1 Food Science
Q2 Molecular Biology
Q1 Physiology
24.
Vass, V., Szabó, E., Bereczki, I., Debreczeni, N., Borbás, A., Herczegh, P., Tósaki, Á.: Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts.
Eur. J. Pharm. Sci. 185, 1-14, (article identifier: 106449), 2023.
doi DEA Scopus
Journal metrics:
Q1 Pharmaceutical Science
25.
Demeter, F., Bényei, A., Borbás, A., Herczeg, M.: Synthesis of the Three Most Expensive L-Hexose Thioglycosides from D-Glucose.
Synthesis. 55 (7), 1087-1111, 2023.
doi DEA WoS Scopus
Journal metrics:
Q3 Catalysis
Q2 Organic Chemistry
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.